We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ekf Diagnostics Holdings Plc | LSE:EKF | London | Ordinary Share | GB0031509804 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.40 | 27.10 | 28.60 | 27.40 | 27.40 | 27.40 | 260,265 | 16:21:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 66.64M | -10.1M | -0.0222 | -12.34 | 124.65M |
TIDMEKF
RNS Number : 0971A
EKF Diagnostics Holdings PLC
21 March 2017
EKF Diagnostics Holdings plc
("EKF", the "Company")
PDMR dealing
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.
Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.
The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com Christopher Mills, Non-Executive Tel: 029 2071 0570 Chairman Julian Baines, CEO Richard Evans, FD & COO N+1 Singer (Nomad & Broker) Tel: 020 7496 3000 Alex Price / Shaun Dobson / Alex Laughton-Scott Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated ------- ------------------------------------------------------------------------- a) Name Harwood Capital LLP, as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT") ------- ----------------------------- ------------------------------------------ 2 Reason for the notification ------- ------------------------------------------------------------------------- a) Position/status Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood Capital LLP and a director and shareholder in NAIT ------- ----------------------------- ------------------------------------------ b) Initial notification Initial Notification /Amendment ------- ----------------------------- ------------------------------------------ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------- ------------------------------------------------------------------------- a) Name EKF Diagnostics Holdings plc ------- ----------------------------- ------------------------------------------ b) LEI 213800DXTF3EAUK1AR05 ------- ----------------------------- ------------------------------------------ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------- ------------------------------------------------------------------------- a) Description of Ordinary shares of 1p each ("Ordinary the financial Shares") instrument, type of instrument ISIN Code: GB0031509804 Identification code ------- ----------------------------- ------------------------------------------ b) Nature of the Acquisition of shares transaction ------- ----------------------------- ------------------------------------------ c) Price(s) and volume(s) Price(s) Volume(s) ------------- -------------- 19.5p 8,000,000 ------------- -------------- ------- ----------------------------- ------------------------------------------ d) Aggregated information n/a - Aggregated volume - Price ------- ----------------------------- ------------------------------------------ e) Date of the transaction 20 March 2017 ------- ----------------------------- ------------------------------------------ f) Place of the transaction London Stock Exchange ------- ----------------------------- ------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBXGDXUSDBGRB
(END) Dow Jones Newswires
March 21, 2017 09:47 ET (13:47 GMT)
1 Year Ekf Diagnostics Chart |
1 Month Ekf Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions